Reaction
Acute Leukaemia reporting signals
As of the last recalculation, Acute Leukaemia appears in 1,600 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is DEFERASIROX (PRR 47.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Deferasirox | 91 | 47.3 | 47.4 |
| Hydroxyurea | 37 | 23.3 | 23.3 |
| Azacitidine | 51 | 23.1 | 23.1 |
| Thalidomide | 52 | 19.0 | 19.0 |
| Ruxolitinib | 95 | 18.3 | 18.3 |
| Bleomycin Sulfate | 14 | 17.8 | 17.8 |
| Azacitidine For | 24 | 17.4 | 17.4 |
| Olaparib | 26 | 16.4 | 16.4 |
| Blinatumomab | 12 | 15.1 | 15.1 |
| Melphalan Hydrochloride | 26 | 13.7 | 13.7 |
| Romiplostim | 15 | 13.1 | 13.1 |
| Posaconazole | 14 | 11.3 | 11.3 |
| Imatinib Mesylate | 23 | 10.9 | 10.9 |
| Melphalan | 18 | 10.4 | 10.4 |
| Voriconazole | 22 | 9.5 | 9.5 |
| Posaconazole Delayed-Release | 8 | 9.5 | 9.5 |
| Cytarabine | 41 | 9.1 | 9.1 |
| Erythropoietin | 13 | 8.3 | 8.3 |
| Cladribine | 6 | 8.1 | 8.2 |
| Sofosbuvir | 12 | 8.0 | 8.0 |
| Eltrombopag Olamine | 14 | 8.0 | 8.0 |
| Imatinib | 10 | 7.4 | 7.4 |
| Cyclophosphamide Injection, Solution | 90 | 6.9 | 7.0 |
| Cyclophosphamide | 90 | 6.9 | 7.0 |
| Cyclophosphamide For Injection | 90 | 6.9 | 7.0 |
| Thiotepa | 5 | 6.8 | 6.8 |
| Etoposide | 36 | 6.5 | 6.5 |
| Nilotinib | 14 | 6.2 | 6.2 |
| Venetoclax | 29 | 6.2 | 6.2 |
| Micafungin Sodium | 4 | 6.2 | 6.2 |
| Pertuzumab | 12 | 5.8 | 5.8 |
| Lenalidomide | 171 | 5.8 | 5.8 |
| Eculizumab | 20 | 4.8 | 4.8 |
| Vemurafenib | 4 | 4.3 | 4.3 |
| Ledipasvir And Sofosbuvir | 6 | 4.1 | 4.1 |